LU61171A1 - - Google Patents

Info

Publication number
LU61171A1
LU61171A1 LU61171A LU61171A LU61171A1 LU 61171 A1 LU61171 A1 LU 61171A1 LU 61171 A LU61171 A LU 61171A LU 61171 A LU61171 A LU 61171A LU 61171 A1 LU61171 A1 LU 61171A1
Authority
LU
Luxembourg
Application number
LU61171A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU61171A1 publication Critical patent/LU61171A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU61171A 1969-06-24 1970-06-22 LU61171A1 (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691931910 DE1931910B2 (de) 1969-06-24 1969-06-24 Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe

Publications (1)

Publication Number Publication Date
LU61171A1 true LU61171A1 (enEXAMPLES) 1970-08-26

Family

ID=5737829

Family Applications (1)

Application Number Title Priority Date Filing Date
LU61171A LU61171A1 (enEXAMPLES) 1969-06-24 1970-06-22

Country Status (10)

Country Link
JP (1) JPS50888B1 (enEXAMPLES)
AT (1) AT299452B (enEXAMPLES)
DE (1) DE1931910B2 (enEXAMPLES)
DK (1) DK125230B (enEXAMPLES)
FI (1) FI51765C (enEXAMPLES)
FR (1) FR2053007A1 (enEXAMPLES)
LU (1) LU61171A1 (enEXAMPLES)
NL (1) NL167322C (enEXAMPLES)
NO (1) NO131864C (enEXAMPLES)
SE (1) SE380729B (enEXAMPLES)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
EP0568026A3 (en) * 1992-04-28 1993-11-10 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production process thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS61135913U (enEXAMPLES) * 1985-02-12 1986-08-23
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068863B (enEXAMPLES) * 1954-03-25 1959-11-12
BE556141A (enEXAMPLES) * 1956-03-27

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
EP0568026A3 (en) * 1992-04-28 1993-11-10 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production process thereof
US5654002A (en) * 1992-04-28 1997-08-05 Ss Pharmaceutical Co., Ltd. Piroxicam tablets and production and process thereof

Also Published As

Publication number Publication date
DE1931910A1 (de) 1971-01-07
NO131864B (enEXAMPLES) 1975-05-12
FR2053007A1 (en) 1971-04-16
SE380729B (sv) 1975-11-17
NL7009172A (enEXAMPLES) 1970-12-29
JPS50888B1 (enEXAMPLES) 1975-01-13
NO131864C (enEXAMPLES) 1975-08-20
DE1931910B2 (de) 1974-11-28
NL167322C (nl) 1981-12-16
FI51765B (enEXAMPLES) 1976-12-31
FR2053007B1 (enEXAMPLES) 1974-08-30
FI51765C (fi) 1977-04-12
DK125230B (da) 1973-01-22
AT299452B (de) 1972-06-26

Similar Documents

Publication Publication Date Title
AU429630B2 (enEXAMPLES)
AU5461069A (enEXAMPLES)
FI51765B (enEXAMPLES)
AU2355770A (enEXAMPLES)
AU5712069A (enEXAMPLES)
AU427401B2 (enEXAMPLES)
AU428074B2 (enEXAMPLES)
AU428129B2 (enEXAMPLES)
AU410358B2 (enEXAMPLES)
AT308690B (enEXAMPLES)
AU425297B2 (enEXAMPLES)
AU414607B2 (enEXAMPLES)
AU417208B2 (enEXAMPLES)
AU428131B2 (enEXAMPLES)
AU5133369A (enEXAMPLES)
AU5228269A (enEXAMPLES)
CS153654B1 (enEXAMPLES)
AU5397469A (enEXAMPLES)
AR203167Q (enEXAMPLES)
CS149928B2 (enEXAMPLES)
AU5598769A (enEXAMPLES)
AU5979569A (enEXAMPLES)
AU5079269A (enEXAMPLES)
AU5960768A (enEXAMPLES)
BE733530A (enEXAMPLES)